throbber
WM'fiMfll-II‘MJ
`4m?
`{SSH arm-cs3:
`
`Short communication
`
`Effect of oetirizine, levocetirizine, and dextrocetirizine on
`
`histamine-induced nasal response in healthy adult volunteers
`
`- Getirizine, an effective Hl—reeeptor antagonist. is a remains
`mixtureoftwommiomeutlevoeetirizine (Reunfiomor) and mm
`{5 enmtiom).
`m To investigate the phannaeologie activity of the mo enantiomers of
`oetirizine. we conducted a randomized. double-blind, lbw-way. crossover awdy
`wmtheeitemofneannmtafithSmglevocefirizinASmgdexmfime,
`and 10
`nigoetirizineandmatched placebomnhistamine-induoedchangeainthe
`Whitehall
`nasal airways of 24 healthy volunteers. Four home after a aingie
`subhetsmehalhngedby
`”"1 “m “m "n” “mm “M“
`'
`in both nostrils. Nasal
`oomtrationsmomo.25to32nigmnof'
`Wmmawedbypaasiveanteriorrhinommomryfim).aad
`channinhistaminethrssholdwereealcalatodtomherwflhtheabsolute
`numberafsnemsafisrmhrhsllenge.
`tly attenuated the histamine-
`WMIevnmth'izinemdoetififineeigniflwn
`emedian
`Momdinereaselnmalairwayrefimmbynearlymmom
`moms: Papmm’mo 129M 1.31 Papermamreapetaivelyhrthe
`maximfleummtiommdtheyconoonfimndyinereamdtheflstamine
`thmhoidbylbnrfoldmomfito 32mgml).eomparedwithplaoeba.8neeriug
`mahomwdhybothiwooefirizineandoefirizine.flm,thue
`anfihistamnficefl'hetswerenotseenudthdextroeefirizim.
`WWSM
`shamaaimilaraotifityoflwocefirizineandmdflalneon
`the inhibitionofhistalnine-induoed hereasehinasalruistanoe, indicators that
`the antihistaminio properties ofeetlrizlne are probably attributable to
`levooetil’izim.
`
`new flaw,
`on. It: Emma-1’
`'WUnWflhna-sm’wl
`H
`.
`,
`m :-
`WDIMWMHIMMM.
`Him
`
`W:mm realm
`WMMH‘ID
`
`mushroom
`momma
`
`mammals—mm
`
`
`
`'I‘herohofhistaminehasbeenweildommtedinthe
`pathophys'tology of allergic airway diseases (1—3). An
`mmmdenmdingomthehmfewdmdaof
`thepethomicrohofhistsmineinallergiedisemhas
`beenassooiatedwiththedevelomtot‘spedfioand
`highly efficacious Hl-reoeptor antagonists for sympto-
`Wordiefnfalifigicdmlasrficuhrlyseasonalwd
`perennialallerglcrhinitisaodnrtioaria(4-G).Theflg-
`receptor antagonists. generally called antihistamines,
`have broadly been classed into two categories.
`the
`first— sari second-generation antihistamines. The first-
`motion antihistamines have been associated with
`mudnermayxtemand anticholinergio side-effects.
`particularly aedationand impaired payehomotor antitr-
`itymaodarethereforenotnraehuaedeurrentlan
`contrast, dismantled-moon antihistamines,
`snohaseetirifineJoratadineJndfexofenadinethibit
`fewer sedative and antieholinregic effects and have a
`rapidwsuofaetiommafinsthemidealforsympto-
`mtiereliefoftbeallergiodiaease.
`
`Controlled trials in patients with manual and
`perennial rhinitis have demonstrated that cenrizine is
`effecfiveinattenuatingnasalmdlorocularsymptoma
`resultiasfi'omexperhnentalornsxuralalhrgznerpo-
`m(8-11).Howewr,oetirizineiaaraomatemiatareof
`two enantiomars:
`levoeetirizine (R enaniiomer} and
`democe‘tirizine(Smmflmr).Theahnoftbisetndy
`wastoinvesfiaatetheaetivityofthesetwoenantimers
`on histamine-imd changes in nasal reeisnnoe and
`sneezingio healthyvolumeera.andthenmoompare
`these effectswith those ofcetirizine and placebo.
`
`Mliwm
`
`Sultana
`Mmeiglnheahhymflerfiovoluteersmeamliedinlfi
`My.0ftm.24umem(nhemm15tmhjapdm
`m(memege29yem}wmpletedtheatudy.11wymem
`Free and head name] May on routine luau-tale.“ and
`bioehmiulhbodmtmmoffiwvdmmmoked
`
`339
`
`Apotex, Inc. (IPR2019-00400), EX. 1005, p. 001
`
`Apotex, Inc. (IPR2019-00400), Ex. 1005, p. 001
`
`

`

`Walnut-i.
`
`mmfiwdpmaaayorhuahamafmfl
`They did 11111 Like my medication.
`mwmfimMmmzmMm‘flmmt
`Aflwlmflnwwfimhfomdmmtpfinrwmuudy Thu
`mdymwmdhyhcthimmmmimadthcmfimity
`howiflI-L mumdmmmmkm Wise
`UnivufindllmDJflfiam.
`
`51011111951111
`Mm arm 601.111thWW. rum—way.
`mmnndy. Eachvolmrmutered 11-1le
`schadubmmdwlmdemflsmmdmsm
`
`flwamhmmnmmmm
`mummrmmmmuxmw
`luhlmmhnhrashuiflmulfionflmmimmm
`mummmumm)mmw
`«ummmwwmmmm
`Tomiuimherhemflmofthemmdfimofm
`ommmmmwmmmm:
`mrdufindmemeARmdhmgemm
`minuifldthmughoutnflvifltnfll. 1311!:th
`m applhd w 3!] mm who bid a W nasal airway
`maf418hpflm'hflmdjdmhmuehymthu
`mmmmm
`affllmtrdnlufion.
`
`Mammarlmhmuinnudmmum
`mfimd<tm¢h§mmdomiadwmmm
`mummmhmmmmw
`fifisuimflmmwmmdhqmmhymhcmu
`mmmmmumdmnmmnm.
`Vonmmmumdtarmlmwwm
`
`mahflmmflaflwm mmfim.a.ad,al1bdngwall.flny
`mdmmpohmutoatmdthrcfiuicforkmzfisflma
`Melamine «1—14 days.
`
`mm 111 nasal resistance
`
`mmmmflbfl’flmWWW).
`upwfioulydum‘badt!415fiufiy.ufiudfidlwd_’2§flnmfsm
`MWamnhintommlrfi. mmhdmdbyfln
`“Myanmnmkurfiwuamkvdofmnm
`mmmumumupnuaihhperm’fgu
`mwmmmcmmmmd
`W{Ifl.hfllW,mflMMw-n
`mammnmmsmmmmm
`hmmfimmfirMmmuwm.m
`erdudmmfmmflmmw
`nbwquuflymdiuthefimlsfiuwmbdm
`
`Hisminemalpmominntast
`mmuus.e..s.1 2.4.3.15,md32nam1m
`
`sodium
`mahuminfilfihfil mandphandwmmwmmfw
`Maxim
`MMWWMWMWW
`ulthlfleyernehfl‘nwaiw.flsdfim.m)fla BLT}:
`“WmmmmmfimMmmmm
`thwflnvdmt-n'smmmnm. mm
`whoddxlllulhr‘lfllfihrughm
`wwwivdypm
`fur-1:11 now-fl maymm mmwmhm
`mm
`
`“111:1.Wmduff-unimmh11111411111n“MmJnqunsmmmmmvanmmmmmuu
`mmm-huwn-nmw
`Nullivwrl'mmhwm'h
`
` WWI-Uni} MW Wit-aw WW WWII Finland?
`1
`0.75
`I."
`I.”
`ll.“
`EH1
`1
`DJ!
`0.8:
`I!
`III.“
`I)”
`t
`1.12
`DH
`“3
`1.12
`m
`LL!
`1.41
`1.91
`
`um
`
`3
`
`1.11
`
`125
`
`11
`
`
`
`1.5!!
`
`2.115
`
`on
`
`mm
`
`'umlmmmmm
`Wwa-mwwummmmmwmmmmkmnmuw
`”154F430
`mam:
`“Ml :klflfi
`Mam than
`
`3110
`
`Apotex, Inc. (IPR2019-00400), EX. 1005, p. 002
`
`Apotex, Inc. (IPR2019-00400), Ex. 1005, p. 002
`
`

`

`mmmdmm
`‘l'lhll 1'. Writinaimmmhthmlflwww.5mmamw5mmmmmmmmmmmm
`mmawmm1mmemmmm-ammm
`
`
`WNM‘M-fim—DD
`
`“swung-an.-
`
`datum—amt:-
`
`30-
`
`uhmMn—IMH—
`
`Wmmmmwwmmmaammmmmmewmmmmd ”Nannie-en
`
`mob-mm
`Warm WePsm
`Writ- Icclt‘l'il‘ll ”all!
`With: shadow-(Elms
`mm wafifiuhficflsmfl
`Within wmbflm
`Mall «momenta
`
`MMMmimdoflmiaafiartbeimPAR
`mtfidfimSmhaafierdxbefamhnuflhepmdm
`WWNMJ.
`
`Statilt'naiaflatvsia
`Thempkahammmdhyapmahflamndeneonfl:
`buiscfaprevimamflyfdanMNeJDnth‘nhaflahmeathmud
`Mahmmtrhhufivedmulemuwhmmm
`mqtdredlodatccttlipificlmdmbiinginhimminafiuuhfldn
`mevalwithm motorist;
`Reliable
`WHEN!” tl'lalludytoaflowfwdawom
`All data were expressed as median valuea, and the overall
`mine-nae of chance in hm Whom. and seem.
`andthemherofmmmn'manymmmmmd
`wmmm.uummpmmmm
`“Wmmmmwmuwmflthe
`mkflamnmhudmmmm yam
`“[lflflflfiflfilmm
`mm: ml
`mums )onm
`mafiblenficroeompimr.fio-
`Mmmmmmotreunimmmu
`significant.
`
`Of thezavolunteers recruited mtetheamdy, reenltefor
`foursobjectawereaotinclodedintheovcralleficaey
`analysis. Oncaubjcctauifctcdfromanepisodcot'
`bmnchifieaflerviaitd-andpt‘iortoreocivingthelaat
`mutvieits. and therd'ore did not empkuthe
`catinc study protocol. The other three subjects. despite
`rhethmthattheyweefigiblghkdtoreactto
`hiemineahowingahimmhtethmhold concentration
`of >321):me ateverytreatmentvistt. mms
`mthereforeconaidexed to benot evaluable, and these
`volunteeremereplaced.
`
`Efieuofweemunmaireelstam
`
`Maaanammtofnasalah‘way resistanceuaderplaacbo
`demonstrated that this was iota-cased by histamine
`adndnhmflonina
`mannerflahlel)
`Treatment with bath cetirizine and levocetiririne
`Wmemummmmwmm
`innaaalairwayreaistameatthemaximaleomtraticn
`ofBZmymIvdlhalmoetSWcredocfimoverplacebo
`(Table 1). Bmhuefiflzineandtevocefiriatnewerefom
`to attenuate significantly the effects of histamine at
`oomfl'afimaofzsmd EIEWJWJH
`eontrastJreaanentwith dmreeetirizinedidnot show
`any significant effect on histemhe-indmed increase in
`nasalairwayreaietanceaacompuedtoplweho.
`
`Effect at treatma-a: en melamine 111mm concentration
`
`Aficrtreamentwithplacebo, Mild-(GMJanbjem
`
`demonstrated a hiataminethreshthreshold concentration of
`581mb! Treatment with oetirizine levocetmzlne
`and dextoaetiriztne decreased the number of subject:
`demonstrating a histamine threshoid concentration of
`$8 myml to 7:24 (29%), me (21%), and 13124 (54%),
`reapecfivcht. The histamine threshold concentration
`was significantly incrlascd fourfold flora a median
`vahacofflmslmlafleru'eamtwithplaccbotoa
`median value of 32mm after
`trcaunent with
`cetirizinc
`(P<0.05) or
`levocefirizinc
`(P401125)
`(Fable 2). In contrast. dmttroeefirifine was not found
`town-sigifiomtlythehistamine threshold concentra-
`tiouaecomparedtoplacebo, aathcnumberot‘aubjecta
`withathreahotdconcentrafionbetowfimymlwas 13
`outuf24. Leweetiriziaewasfoundtobeaigntfimdy
`34!
`
`Apotex, Inc. (IPR2019-00400), EX. 1005, p. 003
`
`Apotex, Inc. (IPR2019-00400), Ex. 1005, p. 003
`
`

`

`Wallets].
`
`Murmanfmm
`
`"3
`
`O
`
`mum-Hm mun—m
`em
`
`WWW
`PheeboCetifiziae
`
`was
`was.
`
`wooesubjeet
`
`Figural. Ethelofueatmsntferlihwith placebo. lOmgoetirizine. 5mg levoeetiriziee.end 51115me nineties-
`inducedsneezes
`
`indomdinoressesinnsssiairwaytesistsmebyabnost
`50% we: placebo at the maximal oomtrstion of
`32 mymL Conconfltantly,
`the histamine threshold
`eminent-stint: was Maxed fourfold from 8 to
`32 mgfmi. The number ofsnoeoes induced by histamine
`nasal provocation was also significantly deeressed by
`treatment with oetiridne or levooetitizine. In contrast,
`treatment with dextroeetirizine did not show at similar
`'pmteotive’ effect as compared to placebo.
`Our findings are in accordance with the findings of
`several studies investigating the effects ofeetirisine in
`patients with seasonal and perennial allergic rhinitis.
`Fmaeerd at 8.1. have recently conducted two auction to
`investigatetheefi'eetsofttesnnentwifli 10 mgoetirizine
`on changes in themssl airway resistance et‘ssympto-
`matic seasonal allergic rhinities challenged with immeas-
`ing doubling doses ofbistamine (1?, 18). These authors
`shouted that eefirizine significantly attenuated hista—
`mine-induced hot-eases
`in nasal airway resistance
`{‘NAR) {mi}! 1.5 h after administration (17}, and that
`theeeefi‘eetswmprevsientMZdhafiertrsattnmt
`(18), when oomparedwith phoebe.
`Thisisthefirstmdytoinvesfigatethespeeifioefi'wteof
`eachenantiomrofoefifizine onlhehisumineaindueed
`nasal
`In view of the similarity of the
`antihistaminie effects obsewed foreetirizineandievooe-
`tirizineartdtheiackofanys'mnifioenteffeflsfot
`dextrocetirizineinthisstudy. itislikehrthattheefl'eets
`ofeetitizineinthemsgemeotofaflersicrhinifismdue
`to levomtirizine. Sims estiziznne is composed ofequsl
`qmdtiesofthetwoenmfiomourstndysumtsthat
`
`(P<0.05} more eifeetive than dextrooetinzine in
`increasing the histamine threehoid concentration. A
`comparison between eetirizine and levooetirizine, how-
`ever, didnot showasignifiesnt diffeteme between them
`{table 2).
`
`Eiieet sftrsetmsnt on sneezing
`
`Fig. 1 shows the am of individual u-eatment on the
`lumber of mes induced by histamine ohafienge.
`TteBiInent with either eefirizine or Jevooetiriziue ais-
`nifieantly (P4031) reduced bistamineéndwed esteem,
`but nottreatmentwithdextrocefirizinessmparud to
`placebo (93.0.10).
`
`Evshiathnnfssisty
`
`Them was no special report on health-related problems
`or discomfort (i.e., drowsiness. fatigue. and dry mouth)
`caused by study mediestioms among the volunteers.
`Onlyomsebjeetrepomdanadmsemtor
`WMWSfiyseflmmfirmt
`withievoeetirizieesndwssnotjodaedtobeadireet
`muhoftheemdydrugflomflhiswasssingk-doee
`steelmandthevoitmteersweteinterviewedtlh after
`eaohintskeofthe smdymediestiou.
`
`m I
`
`nthissmdyJemostifizineSmgandoetirizinelflmg
`appuredtobeeomrableintbeirsntihiam'‘nio
`activity. They signiEanlly ammted histamine-
`342
`
`Apotex, Inc. (IPR2019-00400), EX. 1005, p. 004
`
`Apotex, Inc. (IPR2019-00400), Ex. 1005, p. 004
`
`

`

`pmfimofkvooeflrifimatadosenmegmbe
`ussfiilinthemansmentofssssamlmdpemnnial
`alkrgicrhinifishithcmtm.
`In additlnntoits
`antihistaminlc
`,
`levocetirizine at
`the single
`dose 0” mg waswsll tuisnixd by the Winnlccfa, who
`didnotsufisi fromsny siiie-dfocuinthisatndy.
`In conclusion,
`this study demolish-ants that
`
`the
`
`
`
`MWD‘W
`
`Fuxihni studiss are mquirsd to substantiate these
`findingsin patients with onguing seasonal and perennial
`allergic rhinitis
`
`mm
`Wetlnnk Marie-flukMandLéonKaufinsnanfDlCfiud
`mm, BeiniufluuwelissChi-mian Omului'UCB-Phsrms,
`fmbnnfinguthdiupufiflhbhflsfisfimflemtmm
`mfufpwpafiniu‘lefiytm. MMWW byUCB-
`Mammals. Belgium.
`
`m L
`
`13. 001m 1'. (Miami FAR, Dam MP
`8. my 11-], Emma M, Wm MD.
`Wow-anus R. Histamine and its
`memwithhistsnfim:
`Cefiridngiwnsdimmrplsnsboln
`mh:mww,flmam51‘.
`iliesom
`nithsdemntnstionof
`subjwuwiflimmisilsrgicrhinms:
`aditorthuimsattrhinitistndon:
`the threshold oil' the activity by this:
`effects situ- nontmllu! mused pollsn
`Blackwell Sdenfiflu. 19955791400.
`methodsufiliimmmommy.
`chuliwinmsiwirmsnuimm
`imamuimumdnsnlansrsy.
`Rhimlosy issui-sea—m
`unit. 1m as. lmmmol
`can Esp Aim-u immsss—sas.
`[-1. WM 1). Guam P. Assumes“ of
`1998;“1538-645.
`3. Wm MY, Sm IE. Kama MA.
`wlysudhnphmnmlommtiunm
`HWMMMMW 9.MuTmEO.WmuJM.mrrzM—D.
`Ilopii: psflsuts am will ski-gun
`Dis 1907;135:1I65-ll76.
`Osmium outdoor study ofthii
`cwmmmamd
`it. mandinlmlmlof
`efficacy. manddmfiwufwtim
`1995;11:363-373.
`mummies iii iiiiniiis Gin Esp
`Ind safety deflsizi’ne, 10mm. and
`Mary IWMSfl'I—SI.
`MWWIWMJ .l5.CLm1PAR.Cmmmsei-epmm
`mum orihinmnomn-y.
`Allergy Gin Immunol 1996;97:6[7—616.
`5. "Wm PH. M1. of
`Wm 195433359155.
`miliismnluss‘mmymdpomcy.c1in
`1i). Loam”, Whit). Mus-Hm
`Dqul.Comparsiivcstudyof
`16. Hmmwmmflm
`339M lMMIfl-fl
`WMMW
`pmmicststistiulmtimds. New
`6. SMTCGMM'A. HIM
`You-hmmmimmt.
`Winchmnicursimisln: Mina-W
`l?.¥munN.LsmmimJ.MmM.
`mmmnmmm
`mammdmslslierfii
`Eli-W “Wain“
`Whnmnhmlmmml
`etaLOms‘tof-cliasiinthnnsui
`MMYm-t: Mum! Dstkar.
`1996953543454
`antihistmisic sfl'sctoi'iisiiiifinesnd
`”95:213-195.
`ll. Mum-mu! “MM.
`bismuhpfimuwiihw
`1'. Sims FER..Non-cmliscsdwise
`WI—CZMA.
`rhinitis. may 1997;53:205-209.
`Minimise (Hi-MID?
`Comparisonoi‘smacysndnmyof
`ts. WN.WO.MM
`Wlmfixpnflersylm
`mlrhlassndsbsstinsinpmumth
`M.GumN.hum3.PmiG.
`Nstslei‘feiii areetiiisinesiidlorsnflm
`mnmmmm
`mains—m.
`iii 24 hours in pittinis with magic
`WWIWBM.
`rhinitis. Am .1 Thar imam-311.
`11.013411an MAP Kama» L.
`Wmhoidudnufl
`W! in non-specific allergic
`may. Rhinnlm 19351113542.
`
`Apotex, Inc. (IPR2019-00400), EX. 1005, p. 005
`
`Apotex, Inc. (IPR2019-00400), Ex. 1005, p. 005
`
`

`

`Apotex, Inc. (IPR2019-00400), EX. 1005, p. 006
`
`Apotex, Inc. (IPR2019-00400), Ex. 1005, p. 006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket